Corbus Pharmaceuticals Holdings, Inc. CRBP
$3.87
-1.15%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | Insider transaction | 2026-11-02 | View → |
| 8-K | 8-K | 2026-10-15 | View → |
| 4 | 4 | 2026-09-15 | View → |
| 8-K | 8-K | 2026-09-14 | View → |
| 4 | 4 | 2026-08-17 | View → |
| 4 | 4 | 2026-08-12 | View → |
| 4 | 4 | 2026-08-10 | View → |
| 4 | 4 | 2026-08-10 | View → |
| 424B5 | 424B5 | 2026-08-07 | View → |
| 10-Q | 10-Q | 2026-08-06 | View → |
| 8-K | 8-K | 2026-08-06 | View → |
| 8-K | 8-K | 2026-07-06 | View → |
| 4 | 4 | 2026-06-11 | View → |
| 4 | 4 | 2026-06-11 | View → |
| 4 | 4 | 2026-06-11 | View → |
| 4 | 4 | 2026-06-03 | View → |
| 8-K | 8-K | 2026-05-26 | View → |
| 4 | 4 | 2026-05-22 | View → |
| 4 | 4 | 2026-05-21 | View → |
| 4 | 4 | 2026-05-21 | View → |
| 4 | 4 | 2026-05-21 | View → |
| 4 | 4 | 2026-05-21 | View → |
| 4 | 4 | 2026-05-21 | View → |
| 4 | 4 | 2026-05-21 | View → |
| 8-K | 8-K | 2026-05-21 | View → |
| 8-K | 8-K | 2026-05-14 | View → |
| 10-Q | 10-Q | 2026-05-12 | View → |
| 8-K | 8-K | 2026-05-12 | View → |
| 8-K | 8-K | 2026-04-16 | View → |
| 8-K | 8-K | 2026-04-14 | View → |
| 8-K | 8-K | 2026-04-07 | View → |
| DEF 14A | DEF 14A | 2026-04-02 | View → |
| S-3 | S-3 | 2026-03-11 | View → |
| 10-K | 10-K | 2026-03-09 | View → |
| 8-K | 8-K | 2026-03-09 | View → |
| 4 | 4 | 2026-03-04 | View → |
| 8-K | 8-K | 2026-02-25 | View → |
| 4 | 4 | 2026-02-18 | View → |
| 4 | 4 | 2026-02-18 | View → |
| 4 | 4 | 2026-02-18 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $3.87
- Market Cap
- $75.72 million
- 52-Week Range
- $3.73 – $20.56
- Average Volume
- 1.02 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.